References
Sobel JD. Vaginal infections in adult women. Med Clin North Am 1990; 74(6): 1573–602
Sobel JD. Management of patients with recurrent vulvovaginal candidiasis. Drugs 2003; 63(11): 1059–66
Nwokolo NC, Boag FC. Chronic vaginal candidiasis. Management of the post menopausal patient. Drugs Aging 2000; 16(5): 335–9
Scharbo-DeHaan M, Anderson DG. The CDC 2002 guidelines for the treatment of sexually transmitted disease: implications for women’s health care. J Midwifery Womens Health 2003; 48(2): 96–104
Sobel JD. Epidemiology and pathogenesis of recurrent vulvovaginal candidiasis. Am J Obstet Gynecol 1985; 152: 924–35
Sobel JD, Kapernik P, Zervos M, et al. Treatment of complicated Candida vaginitis: comparison of single and sequential doses of fluconazole. Am J Obstet Gynecol 2001; 185: 363–9
Sobel JD, Faro S, Force RW et al. Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations. Am J Obstet Gynecol 1998; 178: 203–11
Daniels D, Forster G. 2002 National guideline on the management of vulvovaginal candidiasis [online]. Available from: http://www.guideline.gov [Accessed 2004 Mar 10]
Watson MC, Grimshaw JM, Bond CM et al. Oral versus intravaginal imidazole and triazole anti-fungal treatment of uncomplicated vulvovaginal candidiasis (thrush). Cochrane Database Syst Rev. 2001; (4): CD002845
British National formulary. No. 47. London: The Pharmaceutical Press, 2004 Mar
Diflucan product information [online]. Available from URL: http://www.diflucan.com [Accessed 2004 Mar 10]
Sobel JD. Fluconazole maintenance therapy in recurrent vulvovaginal candidiasis. Int J Gynecol Obstet 1992; 37: 17–34
Spinillo A, Colonna L, Piazzi G, et al. Managing recurrent vulvovaginal candidiasis: intermittent prevention with itraconazole. J Reprod Med 1997; 42(2): 83–7
Sobel JD. Recurrent vulvovaginal candidiasis: a prospective study of the efficacy of maintenance ketoconazole therapy. N Engl J Med 1986 Dec 4; 315(23): 1455–8
Fong IW. The value of chronic suppressive therapy with itraconazole versus clotrimazole in women with recurrent vaginal candidiasis. Genitourin Med 1992; 68(6): 374–7
Hilton E, Isenberg HD, Alperstein P, et al. Ingestion of yogurt containing Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med 1992; 116(5): 353–7
Lynch ME, Sobel JD. Comparative in vitro activity of antimycotic agents against pathogenic vaginal yeast isolates. J Med Vet Mycol 1994; 32: 267–74
Sobel JD, Chaim W. Therapy of T. glabrata vaginitis: retrospective review of boric acid therapy. Clin Infect Dis 1997; 24: 649–52
Rights and permissions
About this article
Cite this article
Maintenance suppressive azole antifungal regimens are a major advance in controlling recurrent vulvovaginal candidiasis. Drugs Ther. Perspect 20, 7–11 (2004). https://doi.org/10.2165/00042310-200420070-00003
Published:
Issue Date:
DOI: https://doi.org/10.2165/00042310-200420070-00003